Publications:

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients.

Oncotarget

Di Salvatore, Mariantonietta M; Pietrantonio, Filippo F; Orlandi, Armando A; Del Re, Marzia M; Berenato, Rosa R; Rossi, Ernesto E; Caporale, Marta M; Guarino, Donatella D; Martinetti, Antonia A; Basso, Michele M; Mennitto, Roberta R; Santonocito, Concetta C; Mennitto, Alessia A; Schinzari, Giovanni G; Bossi, Ilaria I; Capoluongo, Ettore E; Danesi, Romano R; de Braud, Filippo F; Barone, Carlo C

Publication Date: 2017-03-07

Variant appearance in text: HR: 2578C>A

PubMed Link: 28129643

Variant Present in the following documents:

• Main text
• oncotarget-08-16887.pdf

View BVdb publication page